Microbot Medical (Nasdaq:MBOT) today announced the full market release of its Liberty endovascular surgical robot in the U.S.
Includes Adoption by Globally Recognized Healthcare Systems in the U.S. Market and Demonstrates Broad Market Scalability in ...
Microbot Medical Inc. announced that it has executed a limited market release of the Liberty robotic system for peripheral ...
HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that Harel Gadot, CEO, ...
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that it has successfully executed ...
Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
Zacks Investment Research on MSN
Microbot Medical begins full US launch of LIBERTY system
Microbot Medical MBOT recently announced the successful completion of the limited market release of its LIBERTY Endovascular ...
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries ...
Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular Space HINGHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Microbot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results